Additionally, upregulation of the IL-6/STAT3 pathway has been detected in ER + breast cancer resistant to CDK4/6i palbociclib, which mediates the upregulation of EMT and BCSCs pathways. The gene discussed is STAT3; the disease is breast cancer.